WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms | Synapse
March 3, 2026Open Access
WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms
Puntos clave
Aquablation therapy achieved noninferior relief of lower urinary tract symptoms in comparison to transurethral laser enucleation—this indicates effectiveness.
Short-term follow-up reveals that aquablation maintained ejaculation preservation and reduced the incidence of stress urinary incontinence, promoting good outcomes.
This prospective trial included a partially randomized design, assessing safety and symptom relief across both interventions.
The findings highlight the benefits of aquablation therapy, suggesting a viable option with specific advantages over traditional methods.
Resumen
Aquablation demonstrated noninferior short-term LUTS relief and similar safety compared to LEP, with superior ejaculation preservation and avoidance of SUI in short-term follow-up.